This week, the tiny Balkan state of Northern Macedonia was once again in the news, because the former Yugoslav state of neighboring Bulgaria is not allowed to become a member of the EU. However, there is also good news: in the capital Skopje, a gigantic cannabis plantation was officially opened. About 15,500 kilos of cannabis will be rolled out of this plantation each year!
Read more details about the new cannabis plantation in Northern Macedonia and find the latest cannabis news with the Hemp.im mobile app.
Northern Macedonia to be house for an immense cannabis plantation
The opening of the mega-white factory this week is something of which the 2 million inhabitants of the Balkan country can be sincerely proud of, of course.
Through its Polish subsidiary Pharmacann Polska, PHCANN International opened the huge indoor weed nursery in Skopje with a floor area of no less than 17,800 square meters. PHCANN calls itself a ‘vertically integrated, multinational pharmaceutical cannabis company’, and that includes its own cannabis factories of course, hence the show in Skopje last Monday.
That is already the second cannabis nursery for PHCANN in Northern Macedonia and both facilities are of course built according to the EU GMP guidelines, or ‘Good Manufacturing Practice’. Even though they are not yet allowed to join the EU for the time being in Northern Macedonia, the cannabis grown there is intended for European consumers (and for ‘other global markets that allow legal medicinal cannabis’, according to the company). PHCANN expects to obtain this EU GMP certification in 2021.
More than 15,000 kilos of cannabis are expected to be harvested annually
A maximum of 15,500 kilos of cannabis buds per year can be grown there in Skopje. That will be exported partly in ‘herbal form’ (just as buds), and partly as oil all over the world.
In addition, PHCANN – which is also listed on the New York Stock Exchange – has built a fully equipped ‘cannabinoid research and testing laboratory’ at the new XL cannabis nursery. In that laboratory, microbiological research is done and data on ‘cannabinoids in all forms’ is collected. The lab is built to ensure that all products are made to the highest standards – from planting to packaging and storage – for needy patients around the world,” the company stated.
Northern Macedonia on the path to becoming a major player on the cannabis market
PHCANN’s CEO, Zlatko Keskovski, said at the opening of his new plantation in Skopje that he expects Europe to become the world’s largest market for ‘pharmaceutical-grade cannabis products’ within 5 years.
As such, this facility will be able to meet demand from the UK, Germany, Poland and other countries in the EU that embrace pharmaceutical-grade cannabis, as well as other international markets such as Australia and Brazil.
“PHCANN’s philosophy has always been to put the patient at the heart of what we do, and we’ve implemented advanced technology to ensure we can produce the highest quality pharmaceutical products here,” said the boss himself.
Furthermore, there’s a lot of hard work for the cannabis sector in Northern Macedonia. However, by way of comparison, from 2021 onwards this PHCANN cannabis nursery will grow about 5 times as much cannabis as Bedrocan grows in the Netherlands after 20 years of operation.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in CNNBS, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Trusters and Leone Investments Finally Receive Approval Under EU Regulation
After almost a month under the new EU Regulation, two platforms, including the historic Trusters launched in 2018 and the...
Coinbase Wallet Has a New Feature: Send Crypto via Web Link
The exciting part is actually in the small print: This is because Coinbase covers the fees for transactions via stablecoin...
Sanofi Reaches an Agreement with Aqemia for $140 Million in Generative AI
Paris-based Aqemia will receive upfront and milestone payments under the deal that will be used to deepen R&D. In addition,...
Burkina Faso and the United Nations Review the Achievements of the Peacebuilding Fund
Eligible since 2017, Burkina Faso has already benefited from the fund's support through the financing of various projects to the...
Malta Approves Three New Cannabis Clubs and Holds First Harm Reduction Training Sessions
According to Malta's rules on cannabis clubs, only the societies listed on the ARUC website can grow and distribute cannabis...
Africa2 weeks ago
Bank of Africa Registered Sustained Growth in the Third Quarter
Crypto1 week ago
Bitcoin Soars 130% This Year: Will It Reach New All-Time Highs in 2024?
Biotech1 week ago
SeniorDomo Continues Commitment Abroad and Starts Operations in France
Biotech3 days ago
Roche Will Pay Up to €2.8 Billion for Carmot Therapeutics